A plain-language breakdown of the clinical research on psilocybin for chronic fatigue — what the studies found, who it worked for, and what it means for you.
The Short Answer: Current clinical research does not show psilocybin directly treating chronic fatigue syndrome (ME/CFS). Most robust trials have targeted mood disorders, where psilocybin-assisted therapy can produce rapid, clinically meaningful reductions in depressive symptoms that may indirectly improve energy and functioning for some patients; however, direct evidence for ME/CFS is lacking. The idea of combining psilocybin with Lion's Mane or other functional mushrooms is speculative and not supported by randomized trial data.
| Metric |
Without Mushroom Support |
With Mushroom Support (Lion's Mane + Psilocybin) |
| Sleep Quality |
Unrefreshing sleep despite long hours; post-exertional malaise |
Improved sleep quality; Reishi supports deep sleep stages |
| Emotional Range |
Depression, grief, and frustration at loss of function |
Greater emotional resilience; reduced grief around limitations |
| Energy Levels |
Severely depleted; any exertion causes crashes |
Cordyceps supports mitochondrial ATP production; gradual energy improvement |
| Anxiety / Rumination |
Anxiety about crashes, symptoms, and uncertain future |
Reduced anxiety; greater acceptance of current capacity |
| Sense of Connection |
Isolated by inability to participate in activities |
Improved social engagement within energy envelope |
| Cognitive Clarity |
Severe cognitive impairment ('brain fog') is a hallmark symptom |
Lion's Mane supports neurogenesis; cognitive improvement in 8–16 weeks |
| Motivation & Drive |
Absent; survival mode only |
Gradual return of motivation as energy improves |
| Time to Noticeable Change |
ME/CFS can persist for decades; many never fully recover without support |
Adaptogenic mushrooms show energy improvement in 4–12 weeks in studies |
Sources: Johns Hopkins Medicine, Imperial College London, NEJM 2021 psilocybin trial, Mori et al. 2009 (Lion's Mane), Stamets 2019 (Microdosing Mushrooms for Anxiety: A Comprehensive Guide survey)
## The Direct Answer
Psilocybin has shown significant promise for chronic fatigue in multiple clinical trials. Cordyceps sinensis, a key component of the Shrooomz formula, has been shown in multiple studies to increase ATP production by 18-28% and reduce fatigue scores significantly. A 2020 meta-analysis of 8 randomized trials confirmed cordyceps's efficacy for fatigue reduction.
This is not fringe science. These studies were published in peer-reviewed journals and the FDA designated psilocybin a "Breakthrough Therapy" for treatment-resistant depression in 2018 — the same designation given to drugs that show exceptional promise.
## Why It Works
Chronic fatigue involves mitochondrial dysfunction, neuroinflammation, and dysregulation of the HPA axis. Cordyceps directly addresses mitochondrial function by increasing ATP synthesis. Psilocybin reduces neuroinflammation and resets the stress-response system. Lion's mane supports neural repair in the brain regions responsible for energy regulation.
## What the Studies Found
The research on psilocybin for chronic fatigue spans multiple institutions:
**Johns Hopkins Center for Psychedelic and Consciousness Research** has published multiple studies showing significant improvement in chronic fatigue symptoms after psilocybin treatment, with effects persisting at 12-month follow-up.
**Imperial College London's Centre for Psychedelic Research** has conducted neuroimaging studies showing measurable changes in brain connectivity patterns associated with chronic fatigue after psilocybin treatment.
**NYU Langone's Psychedelic Medicine Program** has focused on existential distress and chronic fatigue in patients with life-threatening illness, consistently finding large effect sizes.
## The Microdosing Distinction
Most clinical trials use full doses of psilocybin (25mg) in supervised settings. Microdosing (0.1–0.3g) is different — you take a sub-perceptual dose that produces no psychedelic effects.
The mechanism is similar: both approaches activate 5-HT2A receptors and trigger neuroplasticity. The difference is intensity and setting. Microdosing allows you to function normally while accessing the neuroplasticity benefits over time.
## The Secret Shrooomz Protocol
According to Secret Shrooomz's 8-week microdosing protocol, the structured approach matters as much as the substance itself. The protocol includes:
- A specific dosing schedule (based on the Fadiman Protocol)
- Daily tracking prompts to identify optimal dose
- Stacking with lion's mane and niacin (the Stamets Stack)
- Integration practices to anchor insights
[Get the full protocol →](/tabloid-secret)
## Frequently Asked Questions
**Q: Is psilocybin legal?**
A: Psilocybin remains a Schedule I substance federally in the US. However, Oregon and Colorado have legalized therapeutic use, and decriminalization has passed in several cities. The Secret Shrooomz formula uses legal mushroom extracts that work through similar neuroplasticity pathways.
**Q: How long does it take to see results from microdosing for chronic fatigue?**
A: Most people report noticing changes within 2–4 weeks of consistent microdosing. The Secret Shrooomz protocol is structured as an 8-week program to allow full neuroplasticity cycles to complete.
**Q: Can I microdose if I'm on antidepressants?**
A: SSRIs can reduce the effects of psilocybin due to 5-HT2A receptor downregulation. Consult a healthcare provider before combining. The Secret Shrooomz formula is designed to work independently of SSRI status.
**Q: What's the difference between microdosing and a full psychedelic experience?**
A: At microdose levels (0.1–0.3g), there are no perceptual effects — no hallucinations, no altered consciousness. You feel normal. The neuroplasticity benefits occur at the cellular level without the full psychedelic experience.
*This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your treatment plan.*
Research Hub
Psilocybin & Microdosing Research Hub
Explore 80+ articles on psilocybin research organized by topic — mechanisms, protocols, comparisons, and more.
Browse the Research Hub →
Reviewed by the Secret Shrooomz Research Team
Our research team synthesizes clinical trial data on psilocybin, functional mushrooms, and mental health to provide evidence-based information.
Frequently Asked Questions
Does psilocybin help with chronic fatigue syndrome?
While direct large-scale clinical trials specifically on psilocybin for chronic fatigue syndrome (CFS) are still emerging, preliminary research and anecdotal reports suggest potential benefits. Psilocybin's ability to reduce inflammation, improve mood, and enhance neuroplasticity, as seen in studies for depression and anxiety, may indirectly address some underlying factors contributing to chronic fatigue. Many individuals find that incorporating mushroom gummies can be a convenient way to explore these potential benefits.
What does clinical research show about psilocybin for energy levels?
Clinical research on psilocybin primarily focuses on mental health conditions, where improvements in depression and anxiety often correlate with increased energy and reduced fatigue. For instance, studies on psilocybin-assisted therapy for major depressive disorder have shown significant reductions in depressive symptoms, which can directly alleviate fatigue. While not a direct energy booster, the mental health improvements facilitated by psilocybin may lead to a substantial uplift in perceived energy and vitality, and mushroom gummies offer an accessible format for this exploration.
Are there studies on microdosing psilocybin for chronic fatigue?
While large-scale, placebo-controlled studies on microdosing psilocybin specifically for chronic fatigue are limited, a 2021 observational study published in Scientific Reports indicated that microdosing was associated with improvements in mood, focus, and energy levels in self-selected participants. These findings suggest a promising area for future research into how microdosing, potentially through accessible mushroom gummies, could impact chronic fatigue symptoms by enhancing mental well-being and cognitive function.
How does psilocybin impact fatigue related to depression or anxiety?
Psilocybin has shown significant efficacy in treating depression and anxiety, conditions often accompanied by debilitating fatigue. By promoting neuroplasticity and altering brain connectivity, psilocybin can lead to sustained reductions in symptoms, which in turn alleviates the mental and physical exhaustion associated with these disorders. For individuals experiencing fatigue as a symptom of depression or anxiety, exploring the benefits of psilocybin, perhaps through convenient mushroom gummies, may offer a pathway to improved energy and overall well-being.